Health Care/Hospital

Nearly VND 20 billion sponsored by Vingroup for research projects on response to novel coronavirus

HANOI, Vietnam, Feb. 21, 2020 /PRNewswire/ -- 3 units funded by Vingroup Innovation Foundation (VINIF) include The Company for Vaccine and Biological Production No.1 (Vabiotech), Pasteur Institute inHo Chi Minh City and Institute of Preventive Medicine and Public Health.

2020-02-21 10:09 3548

Yum China Stands with Communities to Fight Coronavirus

SHANGHAI, Feb. 20, 2020 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE: YUMC) today announced that it has been actively mobilizing resources in a multi-pronged response to the outbreak of novel coronavirus (COVID-19). As part of its efforts, the Company immediately ...

2020-02-21 09:54 12152

S-CELL Becomes the First in Asia to Introduce Consumer Epigenetics Testing and is the Most Advanced Test in the World

HONG KONG, Feb. 21, 2020 /PRNewswire/ -- S-CELL, in partnership with Chronomics, is the first company inAsia to introduce Healthspan, the most advanced epigenetic testing service in the world. Chronomics was established in 2017 and later officially launched the epigenetics testing kit in hopes to...

2020-02-21 09:20 2224

VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update

AUSTIN, Texas, Feb. 20, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the full fiscal year endedDecember 31, 2019. Volition management will host a conference call tomorrow,February 21, at 8:30 a.m. U.S. Easte...

2020-02-21 05:10 10107

StoneWise AI-driven Drug Discovery Platform: Investigation and Repurpose of Nucleoside-based RNA Polymerase Inhibitors and Their Potential Use in COVID-19 Infection Treatment

BEIJING, Feb. 20, 2020 /PRNewswire/ -- In a campaign to screen drugs for the treatment of COVID-19, the disease caused by SARS-CoV-2, StoneWise, a company specialized in applying artificial intelligence to innovative drug design solutions for innovative drug R&D enterprises and institutions, has ...

2020-02-20 20:04 1413

Hyatt Regency Danang Resort and Spa Implemented Precautionary COVID-19 Measures

DA NANG, Vitenam, Feb. 20, 2020 /PRNewswire/ -- The safety and wellbeing of the guests and colleagues is a top priority. Hyatt hotels globally, including Hyatt Regency Danang Resort and Spa, have already implemented precautious measures in response to coronavirus concerns, including colleague edu...

2020-02-20 19:15 4263

Sihuan Pharmaceutical Announces Acquisition of All Interests and Intellectual Property Rights of Plazomicin, A New Generation of Aminoglycoside Antibiotics in the Greater China Region

HONG KONG, Feb. 20, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460, "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that Xuanzhu (HK) Biopharmaceutical Limited (''Xuanzhu''), a wholly-owned subsidiary of the...

2020-02-20 18:59 13134

111 to Announce Fourth Quarter and Fiscal Year 2019 Unaudited Financial Results on March 12, 2020

SHANGHAI, Feb. 20, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform inChina , today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2019 endedDecember 31, 2019, bef...

2020-02-20 17:15 10322

111 Partners with Financial Institutions in Battle Against Coronavirus

SHANGHAI, Feb. 20, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI, "111" or the "Company") has announced that it will leverage its knowhow and technology in the battle against the novel coronavirus (COVID-19) public health crisis, through partnerships with some ofChina's leading financial institution...

2020-02-20 17:00 5341

Ten billion investment to build Chengdu medical city to create a new highland for the international health industry

CHENGDU, China, Feb. 20, 2020 /PRNewswire/ -- In 2019, with the continuous advancement of "three medical integration", Chengdu Medical City's three medical innovation center, as "Western China Biomedical Innovation Center", submitted a satisfactory answer sheet: 58 new contracted projects (47 thr...

2020-02-20 16:04 770

Hummingbird Bioscience Announces Agreement with Mycenax Biotech for Production of Anti-VISTA Antibody HMBD-002 for Cancer Clinical Trial

HOUSTON, Feb. 20, 2020 /PRNewswire/ -- Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery of new breakthrough antibody therapeutics for difficult-to-treat conditions, today announced it has signed an agreement with Mycenax Biotech for the production of material...

2020-02-20 15:15 1598

Industrial enterprises in Weifang, Shandong resume work and production while fighting epidemic

WEIFANG, China, Feb. 20, 2020 /PRNewswire/ -- In order to respond to the epidemic of novel coronavirus pneumonia (NCP), the government ofShandong Province has issued a notice that requires enterprises that are key to national economy and people's livelihoods to immediately resume work and product...

2020-02-20 13:37 1286

Infinitus releases 2019 Corporate Social Responsibility Report promoting a healthy lifestyle

GUANGZHOU, China, Feb.20, 2020 /PRNewswire/ -- The general public has come to see the taking of social responsibility as a basic requirement of all companies. On February 20, Infinitus (China) Company Ltd released its 2019 Corporate Social Responsibility Report on its online platform. Given th...

2020-02-20 10:00 2232

InDex Pharmaceuticals' In-depth Analysis of the CONDUCT Study Confirms the Successful Top Line Results and Supports the Strategy Going Forward

STOCKHOLM, Feb. 20, 2020 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced the conclusions from in-depth analysis of the complete data set from the phase IIb dose optimisation study CONDUCT, evaluating the first-in-class TLR9 agonist cobitolimod for the treatment of moderate...

2020-02-20 06:00 1666

Nimble Announces Collaboration with Genentech to Discover and Develop Novel Peptide-Based Therapeutics

MADISON, Wisconsin, Feb. 20, 2020 /PRNewswire/ -- Nimble Therapeutics, Inc. today announced a multi-year collaboration with Genentech, a member of the Roche Group, to accelerate discovery and development of novel peptide-based medicines for targets across a range of diseases. The collaboration w...

2020-02-20 01:00 1986

Telangana State and MedTechConnect launch Project Tej

HYDERABAD, India, Feb. 19, 2020 /PRNewswire/ -- In order to provide a platform which can enable aspiring entrepreneurs to test their innovative ideas in the field of medical technologies, TheGovernment of Telangana and MedTechConnect, a platform founded by Cyient and Xynteo's India2022 coalition ...

2020-02-19 20:01 1957

TAT's travel recommendations regarding Thailand's Coronavirus Disease 2019 control measures

BANGKOK, Feb. 19, 2020 /PRNewswire/ -- On Thursday, 30 January, 2020, the World Health Organisation (WHO) declared the outbreak of the Coronavirus Disease (COVID-19) as a Public Health Emergency of International Concern (PHEIC). The WHO did not recommend any travel or trade restrictions based on ...

2020-02-19 19:48 1566

Conduent Market-Leading Disease Surveillance and Outbreak Management System to Fight Coronavirus

FLORHAM PARK, N.J., Feb. 19, 2020 /PRNewswire/ -- Conduent Incorporated  (Nasdaq: CNDT) today announced a version of its disease surveillance and outbreak management platform, Maven®, to securely track, manage and report on cases of the coronavirus, COVID-19, previously...

2020-02-19 18:04 6758

Announcement of Memorandum of Understanding for Launching Strategic joint venture of 5G network service business

TOKYO, Feb. 19, 2020 /PRNewswire/ -- BitOne Group Company Limited (hereinafter "The Company") and IBO Telecom Company Limited (hereinafter "IBO Telecom"), a Hong Kong-based subsidiary of IBO Technology Company Limited ("IBO Technology") are pleased to announce that we have signed a memorandum of ...

2020-02-19 17:00 2473

NeuroVive Pharmaceutical AB Year End Report January - December 2019

STOCKHOLM, Feb. 19, 2020 /PRNewswire/ -- Important events in 2019 KL1333            * NeuroVive enrolls first subject in its European KL1333 phase Ia/b clinical study            * NeuroVive initiates second part of its ongoing KL1333 Phase Ia/b clinical study            * NeuroVive compl...

2020-02-19 16:08 6311
1 ... 820821822823824825826 ... 847